Abstract
The goal of personalised therapy based on hepatocellular carcinoma (HCC) molecular characteristics is still beyond our grasp. Systemic treatments show poor efficacy, mainly because of the great heterogeneity of the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have